Tag Archives: aggressive

Blog

MHRA grants conditional marketing authorization for AbbVie’s Tepkinly to treat aggressive blood cancer

Posted on by info
MHRA grants conditional marketing authorization for AbbVie’s Tepkinly to treat aggressive blood cancer
29
Oct

AbbVie today announced that the UK Medicines and Healthcare products Regulatory Agency has granted conditional Marketing Authorisation for Tepkinly® (epcoritamab) as a monotherapy for the treatment of adults with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL), after two or more systemic therapies. The conditional Marketing Authorization for Great Britain is predicated on the […]

Continue reading →
Blog

Recent insights into how aggressive cancer cells proliferate and propagate the disease

Posted on by info
Recent insights into how aggressive cancer cells proliferate and propagate the disease
07
Jun

Not all cancer metastases have the identical destructive effect. Researchers reveal different mechanisms in experiments. A recent paper in “Cell Reports”, co-led by Dr. Christina Scheel from the Skin Cancer Center on the Ruhr University Bochum, Germany, presents recent mechanistic insights into how essentially the most aggressive cancer cells proliferate and propagate the disease. The […]

Continue reading →